Detalhe da pesquisa
1.
SARS-CoV-2 mRNA-vaccine candidate; COReNAPCIN®, induces robust humoral and cellular immunity in mice and non-human primates.
NPJ Vaccines
; 7(1): 105, 2022 Sep 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36056015
2.
Variants in ACE2; potential influences on virus infection and COVID-19 severity.
Infect Genet Evol
; 90: 104773, 2021 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-33607284